- Home
- Publications
- Publication Search
- Publication Details
Title
Immunosuppressive Drugs and COVID-19: A Review
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-28
DOI
10.3389/fphar.2020.01333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- COVID-19 infection: the perspectives on immune responses
- (2020) Yufang Shi et al. CELL DEATH AND DIFFERENTIATION
- Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients
- (2020) Yun Ling et al. CHINESE MEDICAL JOURNAL
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)
- (2020) Kaijin Xu et al. CLINICAL INFECTIOUS DISEASES
- Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
- (2020) Raef Fadel et al. CLINICAL INFECTIOUS DISEASES
- Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China
- (2020) Jianlei Cao et al. CLINICAL INFECTIOUS DISEASES
- Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China
- (2020) Pingzheng Mo et al. CLINICAL INFECTIOUS DISEASES
- Tocilizumab in transplantation
- (2020) Banafsheh Mosharmovahed et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
- (2020) Ruggero Capra et al. European Journal of Internal Medicine
- Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
- (2020) Corrado Campochiaro et al. European Journal of Internal Medicine
- Risk-adapted Treatment Strategy For COVID-19 Patients
- (2020) Changcheng Zheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
- (2020) Xiaochen Li et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian Centre study on tocilizumab versus standard of care
- (2020) Luca Quartuccio et al. JOURNAL OF CLINICAL VIROLOGY
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
- (2020) Xiaowei Fang et al. JOURNAL OF INFECTION
- Why tocilizumab could be an effective treatment for severe COVID-19?
- (2020) Binqing Fu et al. Journal of Translational Medicine
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
- (2020) T. Klopfenstein et al. MEDECINE ET MALADIES INFECTIEUSES
- Corticosteroid treatment of patients with coronavirus disease 2019 ( COVID ‐19)
- (2020) Lei Zha et al. MEDICAL JOURNAL OF AUSTRALIA
- Recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (Covid-19) en pacientes con trasplante renal
- (2020) Verónica López et al. NEFROLOGIA
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab
- (2020) M. Cellina et al. Diagnostic and Interventional Imaging
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)
- (2020) Marta Colaneri et al. Microorganisms
- Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
- (2020) Emanuel Della-Torre et al. ANNALS OF THE RHEUMATIC DISEASES
- IMPACT OF GLUCOCORTICOID TREATMENT IN SARS-COV-2 INFECTION MORTALITY: A RETROSPECTIVE CONTROLLED COHORT STUDY
- (2020) Ana Fernández Cruz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-dose but Not Low-dose Corticosteroids Potentially Delay Viral Shedding of Patients With COVID-19
- (2020) Sijia Li et al. CLINICAL INFECTIOUS DISEASES
- Bloodstream infections in critically ill patients with COVID‐19
- (2020) Daniele Roberto Giacobbe et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Cyclophilin Inhibitors Restrict Middle East Respiratory Syndrome Coronavirus Via Interferon λ In Vitro And In Mice
- (2020) Lucie Sauerhering et al. EUROPEAN RESPIRATORY JOURNAL
- A Comprehensive Review of Tocilizumab in COVID‐19 Acute Respiratory Distress Syndrome
- (2020) Sajad Khiali et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Methylprednisolone added to tocilizumab reduces mortality in SARS‐CoV‐2 pneumonia: An observational study
- (2020) F. Sanz Herrero et al. JOURNAL OF INTERNAL MEDICINE
- Antiviral activities of mycophenolic acid and IMD‐0354 against SARS‐CoV‐2
- (2020) Fumihiro Kato et al. MICROBIOLOGY AND IMMUNOLOGY
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case–controlled study
- (2020) G Rojas-Marte et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Effects of Corticosteroid Treatment for Non-Severe COVID-19 Pneumonia
- (2020) Mingli Yuan et al. SHOCK
- A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
- (2020) Jonathan Rilinger et al. Trials
- Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19
- (2020) Xudan Chen et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: A cohort study
- (2019) Sarah H. Alfaraj et al. Travel Medicine and Infectious Disease
- High-throughput Screening and Identification of Potent Broad-spectrum Inhibitors of Coronaviruses
- (2019) Liang Shen et al. JOURNAL OF VIROLOGY
- Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication
- (2019) Yue Ma-Lauer et al. ANTIVIRAL RESEARCH
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
- (2018) Yaseen M. Arabi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model
- (2018) H.S. Li et al. ANTIVIRAL RESEARCH
- Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
- (2018) Min-Han Lin et al. ANTIVIRAL RESEARCH
- The role of adjuvant immunomodulatory agents for treatment of severe influenza
- (2018) David S. Hui et al. ANTIVIRAL RESEARCH
- Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists
- (2018) Hiroki Mitoma et al. CYTOKINE
- MERS, SARS and other coronaviruses as causes of pneumonia
- (2017) Yudong Yin et al. RESPIROLOGY
- Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance
- (2016) Chunlong Ma et al. ANTIVIRAL RESEARCH
- Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia
- (2016) Mohammed Al Ghamdi et al. BMC INFECTIOUS DISEASES
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus
- (2015) Kai-Wen Cheng et al. ANTIVIRAL RESEARCH
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
- (2015) Jasper Fuk-Woo Chan et al. JOURNAL OF INFECTIOUS DISEASES
- Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease
- (2015) Reed F. Johnson et al. VIROLOGY
- Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis
- (2014) Jason Kindrachuk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir
- (2014) Javier Carbajo-Lozoya et al. VIRUS RESEARCH
- Interferon- and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
- (2013) B. J. Hart et al. JOURNAL OF GENERAL VIROLOGY
- MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment
- (2013) A. H. de Wilde et al. JOURNAL OF GENERAL VIROLOGY
- Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
- (2013) Jasper F.W. Chan et al. JOURNAL OF INFECTION
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506
- (2012) Javier Carbajo-Lozoya et al. VIRUS RESEARCH
- Cyclosporin A inhibits the replication of diverse coronaviruses
- (2011) A. H. de Wilde et al. JOURNAL OF GENERAL VIROLOGY
- The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
- (2011) Susanne Pfefferle et al. PLoS Pathogens
- The SARS outbreak in a general hospital in Tianjin, China: clinical aspects and risk factors for disease outcome
- (2009) Mao-Ti Wei et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Mouse-Passaged Severe Acute Respiratory Syndrome-Associated Coronavirus Leads to Lethal Pulmonary Edema and Diffuse Alveolar Damage in Adult but Not Young Mice
- (2008) Noriyo Nagata et al. AMERICAN JOURNAL OF PATHOLOGY
- Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
- (2008) Chi-Yuan Chou et al. BIOCHEMICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search